Preventing unwanted pregnancy and HIV infection by using one product could be a reality one day. Early research on several products presented last week at the virtual HIV Research for Prevention (HIVR4P) conference showed that they are safe and that potential users are attracted by the idea of a two-in-one prevention method. High rates of… Read More »
There remains a substantial gap throughout Europe between the need and desire for HIV pre-exposure prophylaxis (PrEP) and the number of people actually using it, an online workshop convened towards the end of last year by the European AIDS Clinical Society (EACS) heard. The workshop on PrEP was the second part of its fourth Standard… Read More »
Scott Morrison says Australia won’t be “completely hostage” to overseas vaccine schedules once it begins to manufacture the AstraZeneca jab onshore. The Therapeutic Goods Administration (TGA) on Monday granted the Pfizer vaccine provisional approval for use in Australia, the first COVID-19 vaccine Supply issues have hampered the delivery of the jab across Europe, and the… Read More »
A study of gay and bisexual male participants in the first large implementation study of HIV pre-exposure prophylaxis (PrEP) in Australia has found that although rates of bacterial sexually transmitted infections (STIs) were high, they did not increase in the two years after starting PrEP. In contrast, they increased significantly in the year before men… Read More »